Measuring the Financial Burden of Resistance: What Should Be Compared?
Clin Infect Dis
.
2019 Aug 30;69(6):1082.
doi: 10.1093/cid/ciz096.
Authors
Klaus Kaier
1
,
Nico T Mutters
2
,
Martin Wolkewitz
1
Affiliations
1
Institute of Medical Biometry and Statistics, University of Freiburg, Germany.
2
Institute for Infection Prevention and Hospital Epidemiology, Faculty of Medicine and Medical Center, University of Freiburg, Germany.
PMID:
30753374
DOI:
10.1093/cid/ciz096
No abstract available
Publication types
Letter
Comment
MeSH terms
Carbapenems
Cost of Illness
Health Expenditures
Humans
Infections*
Klebsiella pneumoniae*
Substances
Carbapenems